548 related articles for article (PubMed ID: 15283924)
1. Techniques to study amyloid fibril formation in vitro.
Nilsson MR
Methods; 2004 Sep; 34(1):151-60. PubMed ID: 15283924
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble beta-sheet models which self-assemble into fibrillar structures.
Janek K; Behlke J; Zipper J; Fabian H; Georgalis Y; Beyermann M; Bienert M; Krause E
Biochemistry; 1999 Jun; 38(26):8246-52. PubMed ID: 10387070
[TBL] [Abstract][Full Text] [Related]
3. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
4. Review: history of the amyloid fibril.
Sipe JD; Cohen AS
J Struct Biol; 2000 Jun; 130(2-3):88-98. PubMed ID: 10940217
[TBL] [Abstract][Full Text] [Related]
5. Effects of sequential proline substitutions on amyloid formation by human amylin20-29.
Moriarty DF; Raleigh DP
Biochemistry; 1999 Feb; 38(6):1811-8. PubMed ID: 10026261
[TBL] [Abstract][Full Text] [Related]
6. Role of the C-terminal 28 residues of beta2-microglobulin in amyloid fibril formation.
Ivanova MI; Gingery M; Whitson LJ; Eisenberg D
Biochemistry; 2003 Nov; 42(46):13536-40. PubMed ID: 14622000
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides.
Rijkers DT; Höppener JW; Posthuma G; Lips CJ; Liskamp RM
Chemistry; 2002 Sep; 8(18):4285-91. PubMed ID: 12298020
[TBL] [Abstract][Full Text] [Related]
8. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils.
Sabaté R; Espargaró A; de Groot NS; Valle-Delgado JJ; Fernàndez-Busquets X; Ventura S
J Mol Biol; 2010 Nov; 404(2):337-52. PubMed ID: 20887731
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
Kapurniotu A; Schmauder A; Tenidis K
J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
[TBL] [Abstract][Full Text] [Related]
10. Structure and morphology of the Alzheimer's amyloid fibril.
Stromer T; Serpell LC
Microsc Res Tech; 2005 Jul; 67(3-4):210-7. PubMed ID: 16103997
[TBL] [Abstract][Full Text] [Related]
11. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
Benseny-Cases N; Cócera M; Cladera J
Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of fibril formation of bovine kappa-casein indicate a conformational rearrangement as a critical step in the process.
Leonil J; Henry G; Jouanneau D; Delage MM; Forge V; Putaux JL
J Mol Biol; 2008 Sep; 381(5):1267-80. PubMed ID: 18616951
[TBL] [Abstract][Full Text] [Related]
13. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin.
Nilsson MR; Raleigh DP
J Mol Biol; 1999 Dec; 294(5):1375-85. PubMed ID: 10600392
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding.
Milton NG; Harris JR
Micron; 2009 Dec; 40(8):800-10. PubMed ID: 19683452
[TBL] [Abstract][Full Text] [Related]
15. Fibrillar beta-lactoglobulin gels: Part 1. Fibril formation and structure.
Gosal WS; Clark AH; Ross-Murphy SB
Biomacromolecules; 2004; 5(6):2408-19. PubMed ID: 15530058
[TBL] [Abstract][Full Text] [Related]
16. Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure.
Lazar KL; Miller-Auer H; Getz GS; Orgel JP; Meredith SC
Biochemistry; 2005 Sep; 44(38):12681-9. PubMed ID: 16171382
[TBL] [Abstract][Full Text] [Related]
17. Structural regulation of a peptide-conjugated graft copolymer: a simple model for amyloid formation.
Koga T; Taguchi K; Kobuke Y; Kinoshita T; Higuchi M
Chemistry; 2003 Mar; 9(5):1146-56. PubMed ID: 12596151
[TBL] [Abstract][Full Text] [Related]
18. Additional supra-self-assembly of human serum albumin under amyloid-like-forming solution conditions.
Juárez J; Taboada P; Goy-López S; Cambón A; Madec MB; Yeates SG; Mosquera V
J Phys Chem B; 2009 Sep; 113(36):12391-9. PubMed ID: 19681594
[TBL] [Abstract][Full Text] [Related]
19. Glucagon fibril polymorphism reflects differences in protofilament backbone structure.
Andersen CB; Hicks MR; Vetri V; Vandahl B; Rahbek-Nielsen H; Thøgersen H; Thøgersen IB; Enghild JJ; Serpell LC; Rischel C; Otzen DE
J Mol Biol; 2010 Apr; 397(4):932-46. PubMed ID: 20156459
[TBL] [Abstract][Full Text] [Related]
20. Protein amyloidose misfolding: mechanisms, detection, and pathological implications.
Jeyashekar NS; Sadana A; Vo-Dinh T
Methods Mol Biol; 2005; 300():417-35. PubMed ID: 15657495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
